# Xiangtan Central Hospital

Organization · id `cardio:org-xiangtan-central-hospital` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Xiangtan+Central+Hospital>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

## Technical summary

Sponsor class other. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Xiangtan Central Hospital
- Sponsor class: OTHER

## Connected pages

- Sponsors: Association Between Dapagliflozin-induced Improvement and Anemia in Heart Failure Patients (ADIDAS) (`cardio:ct-nct04707261`)
- Sponsors: SPT-07A Injection in Patients With Acute Ischemic Stroke (AIS): A Phase III Clinical Trial (`cardio:ct-nct05159947`)
- Sponsors: Intensive Cholesterol-Lowering Within 24 Hours of PCI Perioperative Period (`cardio:ct-nct07290699`)

## Provenance

Content hash: 9bfc8f7b6cee2936b18ce239427a60ffa65ba2f4659d0501012698a93b7a78d3
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
